Procainamide Hydrochloride
NDC 25021-322, Procainamide Hydrochloride, injection, solution, from Sagent Pharmaceuticals.
- Product NDC
- 25021-322
- Status
- Listed
- Labeler
- Sagent Pharmaceuticals
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAMUSCULAR, INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA218135
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/25021-322 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- PROCAINAMIDE HYDROCHLORIDE100 mg/mL
Pharmacologic classes
Antiarrhythmic [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 25021-322-10 | 25021032210 | 10 VIAL in 1 CARTON (25021-322-10) / 10 mL in 1 VIAL |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/358c956e-8c6c-4bd6-a6bc-194d5b3d6d9aMedicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=25021-322
Use it
Look up 25021-322 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/25021-322 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 25021-322. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.